PHESGO Implementation Cuts Chair Time and Boosts Efficiency in HER2-Positive Breast Cancer Care

PHESGO reduced patient infusion time from 90 minutes to as little as 5, enhancing patient experience while maintaining efficacy and safety.

administrator

Related Articles